Effect of cerivastatin sodium, a new inhibitor of HMG-CoA reductase, on plasma lipid levels, progression of atherosclerosis, and the lesional composition in the plaques of WHHL rabbits.
about
Non-lipid-related effects of statins.Cerivastatin: the low-dose HMG-COA reductase inhibitor.Outcome of rheumatoid arthritis following adjunct statin therapyRoles of the WHHL rabbit in translational research on hypercholesterolemia and cardiovascular diseases.Most appropriate animal models to study the efficacy of statins: a systematic review.Endothelial expression of endoglin in normocholesterolemic and hypercholesterolemic C57BL/6J mice before and after atorvastatin treatment.
P2860
Effect of cerivastatin sodium, a new inhibitor of HMG-CoA reductase, on plasma lipid levels, progression of atherosclerosis, and the lesional composition in the plaques of WHHL rabbits.
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Effect of cerivastatin sodium, ...... n the plaques of WHHL rabbits.
@ast
Effect of cerivastatin sodium, ...... n the plaques of WHHL rabbits.
@en
type
label
Effect of cerivastatin sodium, ...... n the plaques of WHHL rabbits.
@ast
Effect of cerivastatin sodium, ...... n the plaques of WHHL rabbits.
@en
prefLabel
Effect of cerivastatin sodium, ...... n the plaques of WHHL rabbits.
@ast
Effect of cerivastatin sodium, ...... n the plaques of WHHL rabbits.
@en
P2860
P356
P1476
Effect of cerivastatin sodium, ...... n the plaques of WHHL rabbits.
@en
P2860
P304
P356
10.1038/SJ.BJP.0702382
P407
P577
1999-02-01T00:00:00Z